In other organs, the MUC4/MUC16/MUC20high group was associated with an increased hazard ratio and reduced overall survival in bladder cancer, colon cancer, lung adenocarcinoma, lung squamous adenocarcinoma, skin cancer, stomach cancer (Additional file 8: Figure S5A). This evidence concerns the gene MUC16 and gastric neoplasm.